Parmax Pharma share news, announcements and annual reports
BSE: 540359Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 26 Oct 2026. Previous close ₹136.40.
26 Oct: open ₹135.05, high ₹135.05, low ₹135.05
- Under BSE's graded surveillance, stage 0, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹93 Cr4,411th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −70.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 657
Parmax Pharma share news and announcements
390 announcements, routine notices left out, newest first. Page 3 of 8.
May 2024
Apr 2024
29 Apr · CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER SEBI REGULATION 40(9)
12 Apr · Compliance Certificate Pursuant To Regulation 7(3)
Feb 2024
14 Feb · Board meeting
7 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Jan 2024
31 Jan · Management
Dec 2023
13 Dec · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And Amendments Thereto ('Listing Regulations').
8 Dec · Intimation Of Fire Accident
Nov 2023
10 Nov · Board meeting
3 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Sep 2023
Aug 2023
17 Aug · Management
15 Aug · Management
14 Aug · Results
14 Aug · Board meeting
7 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
Jul 2023
Jun 2023
May 2023
30 May · Results
30 May · Results
23 May · Board meeting
Meeting on 30 May 2023: audited results
Apr 2023
27 Apr · Management
25 Apr · Management
7 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Year Ended On 31St March, 2023.
Feb 2023
6 Feb · Board meeting
Meeting on 11 Feb 2023: quarterly results
Dec 2022
24 Dec · Legal
23 Dec · Legal
Exchange has sought clarification from Parmax Pharma Ltd on December 23, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Nov 2022
12 Nov · Results
7 Nov · Board meeting
Meeting on 12 Nov 2022: quarterly results
Oct 2022
27 Oct · Legal
21 Oct · Legal
Exchange has sought clarification from Parmax Pharma Ltd on October 21, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....